IDEAYA Biosciences Secures $46,000,000 Series A Funding Round

  • Feed Type
  • Date
    5/5/2016
  • Company Name
    IDEAYA Biosciences
  • Mailing Address
    329 Oyster Point Boulevard 3rd Floor South San Francisco, CA 94080 USA
  • Company Description
    At the core of a successful big biology and small molecule based drug discovery company is well understood pathobiology of the drug targets and excellent chemical matter to modulate them – one without the other ultimately equals failure.
  • Website
    http://www.ideayabio.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $46,000,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    The company is now capitalized to advance its research programs in synthetic lethality and immuno-oncology to clinical candidate selection and the clinic. IDEAYA was incubated by 5AM Ventures with a seed investment prior to its Series A financing.
  • M&A Terms
  • Venture Investor
    5AM Ventures
  • Venture Investor
    Canaan Partners
  • Venture Investor
    Celgene
  • Venture Investor
    WuXi PharmaTech
  • Venture Investor
    Novartis BioVenture Fund
  • Venture Investor
    Alexandria Venture Investments